Log In
Print
BCIQ
Print
Print this Print this
 

XP21279

Also known as: XP21279 SR1

  Manage Alerts
Collapse Summary General Information
Company XenoPort Inc.
DescriptionSustained-release transported prodrug of L-dopa
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase II
IndicationParkinson's disease (PD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today